H. İ. Ellez Et Al. , "Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival," Journal of Bone Oncology , vol.55, 2025
Ellez, H. İ. Et Al. 2025. Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival. Journal of Bone Oncology , vol.55 .
Ellez, H. İ., SEMİZ, H. S., EKİNCİ, F., ERDOĞAN, A. P., Kuş, F., Karataş, F., ... BAYRAM, E.(2025). Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival. Journal of Bone Oncology , vol.55.
Ellez, Halil Et Al. "Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival," Journal of Bone Oncology , vol.55, 2025
Ellez, Halil İ. Et Al. "Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival." Journal of Bone Oncology , vol.55, 2025
Ellez, H. İ. Et Al. (2025) . "Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival." Journal of Bone Oncology , vol.55.
@article{article, author={Halil İbrahim Ellez Et Al. }, title={Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival}, journal={Journal of Bone Oncology}, year=2025}